Fatty liver protection trial by Telmisartan or Losartan Study
Not Applicable
- Conditions
- Hypertension with non alcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000000540
- Lead Sponsor
- Keio University, School of Medicine, Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Not provided
Exclusion Criteria
Drug allergy for the agents. Severe liver dysfunction. Insulin treatment for diabetes mellistus. Malignancy. Recent major macrovascular disease. Severe hypertension.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of liver function (AST, ALT)
- Secondary Outcome Measures
Name Time Method